Date: 2015-02-04
Type of information: Company acquisition
Acquired company: Annovation Biopharma (USA - MA)
Acquiring company: The Medicines Company (USA - NJ)
Amount: undisclosed
Terms: * On February 4, 2015, The Medicines Company announced that it has completed its acquisition of all of the outstanding equity of Annovation Biopharma, a company focused on creating more effective, safer therapies for anesthesia and critical care. Based on technology licensed from Massachusetts General Hospital, Annovation is developing ABP-700, a novel intravenous anesthetic which in Phase 1 clinical studies has demonstrated potent and rapidly reversible anesthetic effects. Currently, ongoing clinical studies have expanded for ABP-700 and additional clinical trials are expected to launch in the second half of this year. The company and its principal investigators expect to present data from the completed Phase 1 trials this fall.
Details:
Related: Critical care
